To investigate the antimicrobial resistance, extended-spectrum b-lactamases (ESBLs) and clones of Klebsiella pneumoniae isolates causing bacteraemia or urinary tract infection (UTI) in Korea, a total of 406 K. pneumoniae isolates from patients with bacteraemia (221 isolates) and UTI (185 isolates) were collected from 10 tertiary-care Korean hospitals from July 2006 to October 2007. In vitro antimicrobial susceptibility testing was performed for all isolates and ESBL production was tested. Multilocus sequence typing (MLST) analyses were performed to characterize genotypes of ESBL-producing K. pneumoniae isolates. PFGE was performed for sequence type 11 (ST11) isolates. Forty-seven UTI isolates (25.4 %) produced ESBLs, while 30 bacteraemia isolates (13.6 %) produced ESBLs (P50.002). Among 77 ESBL-producing isolates, thirty-two (41.6 %) produced SHV-type ESBLs. bla CTX-M genes such as bla CTX-M-14 and bla CTX-M-15 were detected Abbreviations: ConNUH, Chonnam National University Hospital; CubNUH, Chungbuk National University Hospital; CunNUH, Chungnam National University Hospital; DFH, Daegu Fatima Hospital; ESBL, extended-spectrum b-lactamase; GNUH, Gyeongsang National University Hospital; JNUH, Jeju National University Hospital; KNUH, Kyungpook National University Hospital; KSH, Kangbuk Samsung Hospital; KUH, Konkuk University Hospital; MLST, multilocus sequence typing; SMC, Samsung Medical Center; ST, sequence type; UTI, urinary tract infection. 
INTRODUCTION
In Korea, the prevalence of extended-spectrum b-lactamases (ESBLs) in clinical Klebsiella pneumoniae isolates has been reported to be 17.7-30.0 % (Jeong et al., 2004; Kim et al., 2005; Ko et al., 2008a) . SHV-12 is the most common ESBL in K. pneumoniae isolates from Korean hospitals followed by SHV-31, SHV-32 and TEM-52 and also CTX-M-type ESBLs, CTX-M-3, CTX-M-12, CTX-M-14 and CTX-M-15 (Bae et al., 2007; Jeong et al., 2004; Kim et al., 2005; Ko et al., 2008a; Ryoo et al., 2005) . However, most of the previous studies in Korea have been performed on clinical isolates from patients irrespective of whether they cause disease.
Previously, we reported the clonal dissemination of ESBLproducing K. pneumoniae isolates in an intensive care unit in a Korean hospital based on PFGE and multilocus sequence typing (MLST) (Ko et al., 2008b) . Although PFGE has been widely used for epidemiological investigation, MLST has been developed to overcome the limitations of the bandbased typing methods. Because it is highly discriminative and easy to standardize, store and exchange the information, it has been applied successfully for the epidemiological studies of many clinically important pathogens (Maiden et al., 1998) . Several studies have investigated the epidemiology and characteristics of antimicrobial-resistant or virulent K. pneumoniae isolates using MLST (Diancourt et al., 2005; Damjanova et al., 2008; Brisse et al., 2009 ). In particular, Damjanova et al. (2008) showed dissemination of CTX-M-15-producing K. pneumoniae isolates belonging to limited clones in Hungary and suggested convergent population evolution in K. pneumoniae as in meticillinresistant Staphylococcus aureus using MLST.
In this study, we investigated the antimicrobial resistance, prevalence of ESBL, type of ESBL and genotype of K. pneumoniae isolates causing bacteraemia and urinary tract infections (UTIs) from 10 university hospitals in various regions of Korea from July 2006 to October 2007.
METHODS
Collection of K. pneumoniae isolates causing bacteraemia and UTIs. As part of a multicentre surveillance study, a total of 406 K. pneumoniae isolates were obtained from in-and outpatients with UTIs (185 isolates) or bacteraemia (221 isolates) in 10 university hospitals in various regions of Korea: Samsung Medical Center (SMC, Seoul), Kangbuk Samsung Hospital (KSH, Seoul), Konkuk University Hospital (KUH, Seoul), Kyungpook National University Hospital (KNUH, Daegu), Daegu Fatima Hospital (DFH, Daegu), Chonnam National University Hospital (ConNUH, Gwangju), Chungnam National University Hospital (CunNUH, Daejeon), Chungbuk National University Hospital (CubNUH, Cheongju), Gyeongsang National University Hospital (GNUH, Jinju) and Jeju National University Hospital (JNUH, Jeju). The number of isolates recovered from each hospital is described in Antimicrobial susceptibility testing. In vitro antimicrobial susceptibility testing was performed by a broth microdilution method according to CLSI guidelines (CLSI, 2009) . Nine antimicrobial agents were tested: ampicillin, gentamicin, ciprofloxacin, ceftazidime, cefotaxime, aztreonam, imipenem, trimethoprim-sulfamethoxazole and piperacillin-tazobactam. Susceptibility interpretive criteria used were those established in CLSI standard M100-S19 (CLSI, 2009). Escherichia coli ATCC 25922, K. pneumoniae ATCC 700603 and S. aureus ATCC 29213 were used as control strains. For ESBL-positive candidates, which were screened as ceftazidime, cefotaxime or aztreonam MIC ¢2 mg l 21 (CLSI, 2009), production of ESBL was confirmed by a double-disc synergy test using BD BBL Sensi-Disk (Becton Dickinson), according to CLSI guidelines (CLSI, 2009) . Quality control for the production of ESBL test was performed using E. coli ATCC 25922 and K. pneumoniae ATCC 700603.
Detection of bla genes. PCR and sequencing of PCR products were performed to determine the gene responsible for the ESBL activity in the ESBL producers. PCR for bla TEM , bla SHV , bla CTX-M, bla OXA and bla VEB was conducted using previously described PCR primers and conditions (Kim et al., 2005; Girlich et al., 2001) . Both strands of all PCR fragments were sequenced and the types of b-lactamase genes were identified by comparing the sequences to those in the database of G. Jacoby and K. Bush (http://www.lahey.org/Studies/). ISEcp1 was also detected for bla CTX-M -positive isolates by PCR as previously described (Damjanova et al., 2008) .
MLST and PFGE. MLST was performed as described by Diancourt et al. (2005) (http://www.pasteur.fr/recherche/genopole/PF8/mlst/). Briefly stated, PCR fragments of the seven housekeeping genes rpoB, gapA, mdh, pgi, phoE, infB and tonB were obtained from chromosomal DNA and directly sequenced. Allelic profiles and sequence types (STs) were designated at the website (http://www.pasteur.fr/recherche/genopole/ PF8/mlst/Kpneumoniae.html). New alleles and STs were submitted to the MLST website and approved. Clonal complexes were determined by including whole K. pneumoniae MLST data using the program eBURST v3 (Feil et al., 2004) . For PFGE, agarose-embedded bacterial genomic DNA was digested with 20 U XbaI. The restriction fragments were separated by electrophoresis in 0.56 TBE buffer (Chung et al., 2008) . Electrophoresis was performed using CHEF Mapper XA (Bio-Rad).
Statistical analysis. Fisher's exact t-test was used to determine the significant differences in resistance and production of ESBL using SPSS for Windows (version 11.5 software package).
RESULTS AND DISCUSSION
This study is the first nationwide surveillance and molecular characterization of invasive K. pneumoniae isolates from patients with bacteraemia or UTI in Korea.
Antimicrobial resistances and ESBL prevalence
The first finding from this study was that K. pneumoniae isolates from bloodstream infections showed lower antimicrobial resistance rates than isolates from urine cultures, although this was not significant for ampicillin, imipenem and trimethoprim-sulfamethoxazole. While resistance rate was the highest for ampicillin (93.1 %) and the lowest for imipenem (0.3 %) among 406 invasive K. pneumoniae isolates, the resistance rates to the other antimicrobial agents ranged from 18.2 % (cefotaxime) to 24.9 % (ceftazidime) ( Table 2) . Although all ESBLproducing members of the Enterobacteriaceae are considered resistant to third-generation cephalosporins, three and five K. pneumoniae isolates had MICs in the susceptibility range of cefotaxime (8 mg l 21 ) and ceftazidime (4-8 mg l 21 ), respectively. K. pneumoniae isolates from UTIs were more frequently ESBL producers than those from bacteraemia (25.4 % vs 13.6 %; P50.002). Among 47 ESBL-producing isolates from patients with UTIs, 12 isolates were from SMC, 11 from ConNUH, eight from CunNUH, five from KSH, four each from GNUH and JNUH, and three from DFH. Among 30 ESBL-producing isolates from patients with bacteraemia, 20 isolates were from SMC, four from JNUH, two from ConNUH, and one each from KSH, KNUH, CunNUH and CubNUH (Table 1) . Resistance rates of clinical K. pneumoniae isolates in a previous (June-August 2005) investigation were similar to those in the present study (Ko et al., 2008a) .
For gentamicin, ciprofloxacin, ceftazidime, cefotaxime, aztreonam and piperacillin-tazobactam, antimicrobial resistance rates were significantly lower in isolates from blood than in those from urine ( Table 2) . The lower resistance rates in isolates from blood may be associated with lower ESBL production rates in them. Lower resistance rates and lower prevalence rate of ESBL in K. pneumoniae isolates from bloodstream infections have been documented in previous studies (Jones et al., 2004; Kolar et al., 2006) . However, the reason for lower resistance rates in K. pneumoniae isolates from blood is unclear.
As shown in Table 2 , one K. pneumoniae isolate from blood showed imipenem resistance. This isolate was resistant to all antimicrobial agents tested in this study except trimethoprim-sulfamethoxazole. However, it did not produce ESBL. A modified Hodge test was performed for this imipenem-resistant isolate to screen for carbapenemase activity (Lee et al., 2001) . As a result, the imipenem-resistant isolate was positive for carbapenemase activity. Types of bla genes Among 77 ESBL-producing K. pneumoniae isolates, nine different types of ESBL genes were identified: one TEM, four SHVs and four CTX-Ms (Table 3 ). The most prevalent ESBL gene was SHV-12 (17 isolates, 22.1 %), followed by CTX-M-15 (14 isolates, 18.2 %), SHV-31 (13 isolates, 16.9 %) and CTX-M-14 (9 isolates, 11.7 %). While CTX-M-15 was identified in 10.6 % of isolates from UTIs, it was the most prevalent type in bacteraemia isolates (30.0 %). Although TEM-135, SHV-22 and CTX-M-27 were not found in bacteraemia isolates, there were no significant differences in distribution of ESBL genes between UTI and bacteraemia isolates. Although most ESBL-producing isolates contained one ESBL gene, SHV-12 and CTX-M-14, SHV-26 and CTX-M-15, SHV-31 and CTX-M-15, and SHV-31 and CTX-M-22 were identified simultaneously in each isolate. Nineteen isolates possessed SHV-11, but no ESBL genes were found in them. Their ESBL activities may be due to different ESBLs or yet-to-be identified ESBL genes. Alternatively, it is possible that we could not detect the bla genes due to nucleotide changes at the primer sites.
It has been suggested that ISEcp1 may play an important role in the mobility of the bla CTX-M genes as a promoter (Kolar et al., 2006) . ISEcp1 was detected in all but one bla CTX-M -positive K. pneumoniae isolates: a single isolate with CTX-M-27 was not positive for PCR assay of ISEcp1. However, when association of ISEcp1 with CTX-M was screened by a combination of an ISEcp1 forward primer and CTX-M reverse primer (Poirel et al., 2005) , additional seven bla CTX-M -positive isolates showed no PCR products: four CTX-M-14-producing isolates, two CTX-M-15-producing isolates and one CTX-M-22-producing isolate. This may imply that diverse bla CTX-M genes have been incorporated in K. pneumoniae isolates from Korea.
Genotypes
Genotypes of 77 ESBL-producing K. pneumoniae isolates were determined using MLST. As a result, a total of 22 different STs were identified in this study (Table 4) . Of these, 19 STs belonged to 14 clonal complexes, but the other 3 STs were designated singletons. The most prevalent was ST11 (allelic profile 3-3-1-1-1-1-4). ST11 accounted for 57.4 % and 70.0 % of isolates from UTIs Invasive ESBL-producing K. pneumoniae in Korea and bacteraemia, respectively. It was found in most hospitals except DFH; 25 isolates from SMC, nine isolates from ConNUH, four isolates from JNUH, three isolates from KSH, three isolates from CunNUH, two isolates from GNUH, one isolate from KUH and one isolate from CubNUH. Although these ST11 isolates showed similar PFGE results, they may diversify into several subtypes. Specific PFGE patterns were not related with a specific hospital or a specific ESBL gene. Only one to three isolates belonged to the other 21 STs. Thirty-two ST11 isolates contained one or more ESBL genes, consisting of eight combinations (Table 4) . Although it was investigated whether other ESBL genes such as OXA and VEB were present in them, we could not find additional ESBL genes. ST11 has been described in Europe such as Hungary, the Netherlands, France and Spain (http:// www.pasteur.fr/recherche/genopole/PF8/mlst/) and designated epidemic clone III (EC III) (Damjanova et al., 2008) . Dissemination in both Europe and Asia may indicate that ST11 is one of the pandemic clones although there are limited epidemiological data on the worldwide distribution of K. pneumoniae. These ST11 isolates from Korea are characterized by all being ciprofloxacinresistant, while only 25.0 % of other ESBL-producing isolates were resistant to ciprofloxacin (data not shown). However, the combination of different ESBL genes with ST11 isolates may indicate that the ESBL-producing isolates with ST11 have diverse origins. In addition, it can be emphasized that further characterization of ESBL-producing isolates such as assay of bla genes is needed, instead of relying only on the MLST, ribotyping, PFGE, etc. 
3-5-20-1-16-1-12 2 2 Unknown (2) *Allelic profiles are in the following order: gapA, infB, mdh, pgi, phoE, rpoB and tonB. DNo isolates. dAncestor of CC was not designated.
The most prevalent ESBL in ST11 isolates was SHV-12 (13 isolates), followed by SHV-31 (11 isolates (Livermore et al., 2007) . . In the present study, CTX-M-15-producing isolates showed eight different STs. Although outbreaks of clonal strains producing CTX-M-15 have been reported worldwide, several reports also documented clonal diversity of CTX-M-15 based on PFGE type (Abbassi et al., 2008; Livermore et al., 2007) , which suggests horizontal transfer of the bla CTX-M-15 gene. In addition, MLST analyses also indicated that CTX-M-15-producing K. pneumoniae isolates belonged to diverse STs (Elhani et al., 2010; Oteo et al., 2009) . Moreover, different STs were positive for bla CTX-M-15 in each country: STs 1, 11, 14, 17, 20, 35 and 36 in Spain (Oteo et al., 2009); and STs 42, 101, 104, 133, 147 and 321 (Elhani et al., 2010), and STs 11, 15, 17, 34, 37, 48, 218 and 271 in Korea (this study). Therefore, bla CTX-M-14 or bla CTX-M-15 genes might be incorporated frequently into several K. pneumoniae strains including the inter-continently disseminated clone ST11.
Although it was recently reported that most K. pneumoniae isolates causing liver abscess in Korea were ST23, serotype K1 and magA-positive (Chung et al., 2008) , no ST23 ESBLproducing isolates were found in this study, which suggests that different K. pneumoniae infections might be caused by different clones.
Our study may have a few limitations: (i) sufficient K. pneumoniae isolates were not included although 10 hospitals participated in the surveillance; and (ii) the numbers of included isolates were not equal among participating hospitals. However, we propose that ST11 is prevalent in ESBL-producing K. pneumoniae isolates causing bacteraemia and UTIs in Korean hospitals, although a large study including more isolates from more hospitals is required. Isolates of the same ST such as ST11 carried different ESBL genes, which may indicate that more tools employed in the epidemiological study would guarantee better understanding of the evolution of ESBL-producing isolates and tracking of them. In addition, CTX-M-type ESBLs belonged to diverse STs, indicating their frequent introduction into K. pneumoniae.
